Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap.
Saved in:
| Title: | Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap. |
|---|---|
| Authors: | Gray GE; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa Glenda.gray@mrc.ac.za.; South African Medical Research Council, Cape Town, South Africa., Mayer KH; Fenway Health and Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Elizaga ML; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Bekker LG; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Allen M; DAIDS, NIAID, NIH, Washington, DC, USA., Morris L; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., Montefiori D; Duke University, Durham, North Carolina, USA., De Rosa SC; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Sato A; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Gu N; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Tomaras GD; Duke University, Durham, North Carolina, USA., Tucker T; South African Medical Research Council, Cape Town, South Africa., Barnett SW; Novartis Vaccines, Cambridge, Massachusetts, USA., Mkhize NN; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., Shen X; Duke University, Durham, North Carolina, USA., Downing K; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Williamson C; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; National Health Laboratory Service, Cape Town, South Africa., Pensiero M; DAIDS, NIAID, NIH, Washington, DC, USA., Corey L; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Williamson AL; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; National Health Laboratory Service, Cape Town, South Africa. |
| Source: | Clinical and vaccine immunology : CVI [Clin Vaccine Immunol] 2016 Jun 06; Vol. 23 (6), pp. 496-506. Date of Electronic Publication: 2016 Jun 06 (Print Publication: 2016). |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101252125 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1556-679X (Electronic) Linking ISSN: 1556679X NLM ISO Abbreviation: Clin Vaccine Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
